The global biobanking market size reached US$ 53.3 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 77.6 Billion by 2027, exhibiting a growth rate (CAGR) of 6.18% during 2022-2027. More Info:- https://www.imarcgroup.com/biobanking-market

1. Copyright © IMARC Service Pvt Ltd. All Rights Reserved
Global Biobanking Market Research
and Forecast Report 2022-2027
Author: Elena Anderson
Marketing Manager
IMARC Group
© 2022 IMARC All Rights Reserved

2. Report Description
About IMARC Group
International Market Analysis Research and Consulting Group is a leading adviser on
management strategy and market research worldwide. We partner with clients in all regions
and industry verticals to identify their highest-value opportunities, address their most critical
challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological
developments for business leaders in pharmaceutical, industrial, and high technology
organizations. Market forecasts and industry analysis for biotechnology, advanced materials,
chemicals, food and beverage, travel and tourism, nanotechnology and novel processing
methods are at the top of the company’s expertise.
IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and
markets with close cooperation at all levels of the client organization. This ensures that our
clients achieve unmatchable competitive advantage, build more proficient organizations, and
secure lasting results.

3. Report Description
Report Description and Highlights
Global Biobanking Market Research Report 2022-2027:
According to the latest report by IMARC Group, titled "Biobanking Market: Global Industry Trends,
Share, Size, Growth, Opportunity and Forecast 2022-2027," the global biobanking market size
reached US$ 53.3 Billion in 2021.
Biobanking refers to the procedure of collecting and preserving human biospecimens that can be
further used for diagnosis, biodiversity studies, and research. These specimens are stored for several
years and are used by multiple researchers for cross-purpose research studies and to improve the
understanding of health and different diseases. Over the years, biobanking has become a vital
resource in medical research, supporting various types of contemporary research like genomics and
personalized medicine.
Request for a PDF sample of this report: https://www.imarcgroup.com/biobanking-
market/requestsample

4. Report Description
Report Description and Highlights
Global Biobanking Market Trends:
The market is primarily driven by the growing prevalence of infectious and chronic diseases as
biobanking is extensively used to develop diagnostics that can accurately and quickly identify
pathogens. In addition, the escalating demand for regenerative medicine and personalized treatment
represents another major growth-inducing factor. Besides this, health agencies of numerous countries
are investing in virtual biobank network models that help investigators locate biospecimens and data
mining from multiple biobanks. This, coupled with the significant developments in genomics, disease
biology, metagenomics, proteomics, bioenergy, and environmental remediation, are positively
influencing the market growth. Moreover, key players are integrating various advanced technologies
with biobanking that assists healthcare professionals in collecting high-quality and well-annotated
human biospecimens, and understanding pathogenic mechanisms. These advanced methods are also
being utilized to identify therapeutic targets of coronavirus disease (COVID-19), which is also creating a
positive market outlook across the globe.
Looking forward, IMARC Group expects the market to reach US$ 77.6 Billion by 2027, expanding at a
CAGR of 6.18% during the forecast period (2022-2027).
View Report TOC, Figures and Tables: https://www.imarcgroup.com/biobanking-market

5. Report Description
Report Description and Highlights
Key Market Segmentation
The research report includes the following segments:
Breakup by Specimen Type:
•Blood Products
•Solid Tissue
•Cell Lines
•Nucleic Acid
•Others
Breakup by Biobank Type:
•Population-based Biobanks
•Disease-oriented Biobanks
Breakup by Application:
•Therapeutics
•Research

6. Report Description
Report Description and Highlights
Breakup by End User:
•Academic Institutions
•Pharma and Biotech Companies
Breakup by Region:
•North America
•Asia Pacific
•Europe
•Latin America
•Middle East and Africa

7. Report Description
Report Description and Highlights
Competitive Landscape with Key Players:
•Brooks Automation Inc
•Bay Biosciences LLC
•Boca Biolistics
•Ctibiotech
•Cureline Inc
•Firalis
•Greiner Bio-One International GmbH
•Hamilton Company
•Merck KGaA
•ProteoGenex Inc
•Thermo Fisher Scientific Inc
•VWR Corporation (Avantor Inc.)

8. Report Description
Key Questions Answered in the Report
1. What was the size of the global biobanking market in 2021?
2. What is the expected growth rate of the global biobanking market during 2022-2027?
3. What are the key factors driving the global biobanking market?
4. What has been the impact of COVID-19 on the global biobanking market?
5. What is the breakup of the global biobanking market based on the specimen type?
6. What is the breakup of the global biobanking market based on the biobank type?
7. What is the breakup of the global biobanking market based on the application?
8. What is the breakup of the global biobanking market based on the end user?
9. What are the key regions in the global biobanking market?
10. Who are the key players/companies in the global biobanking market?

9. Report Description Table of Contents
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Biobanking Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

10. Report Description Table of Contents
6 Market Breakup by Specimen Type
6.1 Blood Products
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Solid Tissue
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Cell Lines
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Nucleic Acid
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Others
6.5.1 Market Trends
6.5.2 Market Forecast
Click here to visit the complete table of content with list of figures and tables:
https://www.imarcgroup.com/biobanking-market/toc

11. A partial List of our Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
Partial List of Clients

12. A partial List of our Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
Partial List of Clients

13. Report Description
Report Description and Highlights
© 2022 IMARC All Rights Reserved
This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of
International Market Analysis Research and Consulting (IMARC). No part of this publication may be
reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be
used in any form or by and means graphic electronic or mechanical, including photocopying, recording,
taping or by information storage or retrieval, or by any other form, without the express consent of
International Market Analysis Research and Consulting (IMARC).
Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been
based on information and sources believed to be accurate and reliable at the time of publishing.
International Market Analysis Research and Consulting makes no representation of warranty of any kind as to
the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any
loss or damage resulting from opinion, errors or inaccuracies if any found this publication.
IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market
Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of
their respective companies.

14. FOR MORE DETAILS
Visit us at :
Stay With Us:
TELEPHONE: +1-631-791-1145
E-MAIL: sales@imarcgroup.com
https://www.imarcgroup.com
Contact Us